XML 47 R35.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Stock-Based Compensation (Tables)
 3 Months Ended
Mar. 30, 2024
Share-Based Payment Arrangement [Abstract]  
Schedule of stock-based compensation expense under all share-based payment plans [Table Text Block]
Stock-based compensation expense under all share-based payment plans -- our Employee Stock Purchase Plan, stock option plans, stock-settled stock appreciation rights (“SSARs”) and restricted stock units (“RSUs”) -- was included in the results of operations as follows:
 Three Months Ended
March 30,
2024		April 1,
2023
Compensation expense, all share-based payment plans
$1,907 $1,690 
Schedule of share-based compensation, restricted stock units award activity [Table Text Block] The following table summarizes PRSUs and RSUs as of March 30, 2024.
Restricted Stock UnitsNumber
of
Stock
Units		Weighted-
Average
Grant Date
Value		Weighted-
Average
Remaining
Contractual
Life		Unrecognized
Compensation
Cost		Aggregate
Intrinsic
Value
Unvested, January 1, 2024933,843 $16.02    
Granted72,245 21.94    
Forfeited(5,341)15.89    
Vested(187,695)14.32    
Unvested, March 30, 2024813,052 $16.94 1.4 years$5,882 $18,050 
Employee PRSUs764,781 $16.94 1.4 years$5,574 $16,978 
Nonemployee Director RSUs48,271 $16.79 1.1 years$308 $1,072 
Schedule of share-based payment award, stock options, valuation assumptions [Table Text Block]
The fair values of stock-based awards granted were estimated at the dates of grant with the following weighted-average assumptions.
 Three Months Ended
March 30,
2024		April 1,
2023
Volatility rate9.5 %9.6 %
Risk-free interest rate4.3 %4.6 %
Expected dividend yield.4 %.4 %
Expected life of awards (years)3.03.0
Schedule of share-based compensation, stock options activity [Table Text Block] The following table summarizes activity under the stock option plans for the three months ended March 30, 2024.
Stock OptionsNumber
of
Options
Outstanding		Weighted-
Average
Exercise
Price		Weighted-
Average
Remaining
Contractual
Life		Aggregate
Intrinsic
Value
Outstanding, January 1, 20241,688,831 $9.04   
Granted— —   
Exercised(12,256)8.08   
Forfeited— —   
Outstanding, March 30, 2024
1,676,575 $9.05 3.2 years$22,047 
Exercisable, March 30, 2024
1,498,678 $8.74 2.9 years$20,172